文献速递重症综合管理与镇静镇痛

老年危重症住院幸存者出院后百日内居家存活天数与院内康复治疗的关系

Days Alive and at Home After Critical Illness Hospitalization Among Older Adults and Its Association With Delivery of In-Hospital Rehabilitation.
PubMed 文献 · Crit Care Med · 2026-03-10
一句话结论老年ICU幸存者出院后100天居家存活天数中位数为95天,院内康复治疗量越多,居家存活天数越高(每增加1小时,优势比1.08)。

该回顾性队列研究纳入884例(加权n=5,330,486)65岁及以上、社区居住的Medicare受益人中ICU住院后存活出院者,年龄中位数81岁(IQR 75-86),女性占50.5%。主要结局为出院后100天内居家存活天数(DAAH100),中位数为95天(IQR 58.4-100),院内康复治疗中位数为4个单位(约1小时),分布在6天内完成。调整人口学、住院前衰弱和功能状态及住院特征后,院内康复每增加1小时,出院后DAAH100处于最高三个等级之一的优势比为1.08(95%CI 1.04-1.08)。作者认为,老年ICU幸存者居家时间存在显著异质性,院内康复可能改善这一以患者为中心的结局。

要点

  • 老年ICU幸存者出院后100天居家存活天数中位数为95天(IQR 58.4-100),个体间差异显著。
  • 院内康复治疗中位数为4个单位(约1小时),分布在6天内完成。
  • 调整混杂因素后,院内康复每增加1小时,DAAH100处于最高三个等级之一的优势比为1.08(95%CI 1.04-1.08)。
  • 该研究为回顾性队列研究,作者认为院内康复可能改善老年ICU幸存者的居家存活天数。

适用人群与场景

  • 纳入人群:65岁及以上、社区居住的Medicare受益人,ICU住院后存活出院者;年龄中位数81岁(IQR 75-86),女性占50.5%。
  • 研究场景:基于美国国家健康与老龄化趋势研究(NHATS)与Medicare索赔数据(2011-2019)链接的回顾性队列。

研究设计与关键结果

  • 研究类型:回顾性队列研究,数据来源为NHATS与Medicare索赔链接(2011-2019),纳入884例ICU住院(加权n=5,330,486)的老年存活出院者。
  • 主要结局DAAH100计算方法:从100天中减去出院后在急诊科、观察病房、住院医疗、精神科、康复病房、专业护理机构或临终关怀机构的所有天数以及死亡后天数。
  • DAAH100中位数为95天(IQR 58.4-100);院内康复治疗中位数为4个单位(约1小时),分布在6天内完成。
  • 调整人口学、住院前衰弱和功能状态及住院特征后,院内康复每增加1小时,DAAH100处于最高三个等级之一的调整优势比为1.08(95%CI 1.04-1.08)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(原文明确为Retrospective cohort study)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,老年ICU幸存者居家时间存在显著异质性,院内康复可能改善这一以患者为中心的结局。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Older adults hospitalized to the ICU are at risk for functional decline. In-hospital rehabilitation can mitigate functional decline; however, its association with long-term outcomes is unknown. Our objective was to describe days alive and at home (DAAH) in the 100 days (DAAH 100 ) after ICU hospitalization among older adults and evaluate whether in-hospital rehabilitation is associated with improved DAAH 100 .

DESIGN: Retrospective cohort study.

SETTING: National Health and Aging Trends Study linked with Medicare claims (2011-2019).

PATIENTS: Community-dwelling Medicare beneficiaries 65 years old or older who survived ICU hospitalization.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The outcome DAAH 100 was calculated by subtracting all post-discharge days in any of emergency department, observation unit, inpatient medical, psychiatric, rehabilitation unit, skilled nursing or hospice facility, and post-death from 100. The exposure was units of in-hospital rehabilitation, that is, physical and/or occupational therapy. We constructed a proportional odds logistic regression model of DAAH 100 (ordinal) adjusted for demographics, pre-hospitalization frailty and functional status, and hospitalization characteristics. We identified 884 ICU hospitalizations (weighted n = 5,330,486) of older adults discharged alive (age, median [interquartile range (IQR)]: 81 yr [75-86]; 50.5% female). Median DAAH 100 was 95 (IQR: 58.4-100) with median of 4 units (~1 hr) of in-hospital rehabilitation delivered over 6 days. After adjustment, each hour of in-hospital rehabilitation was associated with 8% higher odds of experiencing any of the three highest levels of DAAH 100 after discharge (adjusted odds ratio [95% CI], 1.08 [1.04-1.08]).

CONCLUSIONS: In this nationally representative study of older ICU survivors, the average patient spent 95 of the first 100 post-discharge DAAH; delivery of greater amounts of in-hospital rehabilitation was associated with increased DAAH 100 after discharge. These findings highlight the substantial heterogeneity in time spent at home by older ICU survivors and the potential for in-hospital rehabilitation to improve this important patient-centered outcome.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kim S, Murphy TE, O'Leary JR, et al. Days Alive and at Home After Critical Illness Hospitalization Among Older Adults and Its Association With Delivery of In-Hospital Rehabilitation. Crit Care Med. 2026. PMID: 41805229. doi:10.1097/CCM.0000000000007094

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。